-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhaoke Ophthalmology announced that the company's ciclosporin ophthalmic gel has been approved for marketing by the State Drug Administration. The drug is indicated to promote tear secretion in patients with dry eyes, and is suitable for patients with reduced tear production due to dry eyes to improve their symptoms.
Share
Listen to the news
Zhaoke Ophthalmology announced that the company's ciclosporin ophthalmic gel has been approved for marketing by the State Drug Administration. The drug is indicated to promote tear secretion in patients with dry eyes, and is suitable for patients with reduced tear production due to dry eyes to improve their symptoms.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending